Nealbarbital
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
5-allyl-5-(1,1-dimethylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
Identifiers | |
CAS Number | 561-83-1 ![]() |
ATC code | none |
PubChem | CID 521716 |
ChemSpider | 455089 ![]() |
UNII | 25ATP958PA ![]() |
Synonyms | Nealbarbital, Censedal |
Chemical data | |
Formula | C12H18N2O3 |
Molar mass | 238.28 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s.[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia.
References[edit]
- ^ US Patent 2899435
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |